ABSTRACT
Introduction
The mechanisms responsible for biomineralization of mammalian bone remain unresolved (1) (2) (3) (4) (5) (6) (7) (8) . One theory proposes that biomineralization reactions are initiated within phospholipid membrane-delimited vesicles (matrix vesicles) released into the extracellular matrix by osteoblasts (1, 3, 5, 8) . Another proposes that mineralization is initiated within the "hole zone" of collagen fibrils at the mineralization front of osteoid in a process requiring noncollagenous phosphoproteins (1, 2, 4) . In vitro studies have shown that some of these phosphoproteins can nucleate the formation of apatite crystals when located within collagen or agarose gels (6, 9, 10) . However, most prior studies of biomineralization have not seriously considered whether their models were consistent with the kinetics or spatial patterning with which bone mineralizes in vivo.
Several noncollagenous bone matrix proteins are believed to play an active role in the biochemical reactions involved in bone biomineralization. One of these proteins, bone sialoprotein (BSP), is a sulfated, phosphorylated matrix glycoprotein containing an RGD integrin receptor-binding site (11) . BSP has been proposed to function as an apatite nucleator because it is found in the mineralizing boundaries of bone, dentin and calcifying cartilage tissues (12) (13) (14) (15) (16) (17) co-localizing with the smallest detectable foci of newly forming mineralized matrix in osteoid (18) , and is expressed prior to and during the active mineralization periods of osteoblastic cultures that produce apatite crystals of biological proportions (19, 20) . Furthermore, purified BSP nucleates a small amount of apatite in vitro (9) likely mediated by its polyglutamate sialic acid, and covalently bound phosphate (44 res./mol) (22) . Research to date indicates that BAG-75 is restricted in its expression to actively forming primary or woven bone and dentin (23) (24) (25) (26) . Purified BAG-75 displays a strong propensity to self-associate into supramolecular spherical complexes (10-20 µm diameter) composed of 10-12 nm diameter microfibrils (24, 27) .
Electronegative complexes composed of BAG-75 can sequester millimolar quantities of phosphate ions that are available for crystal nucleation reactions (24) ; BAG-75 also binds up to 135 atoms of Ca +2 /molecule at saturation (28) . Multimeric BAG-75 complexes exist in vivo at sites of new primary bone formation as demonstrated by staining frozen tissue sections with a BAG-75 aggregation-specific monoclonal antibody (24) .
While conclusions from in vitro models require validation in vivo [see Gorski et al., companion paper (29) ], culture systems are readily controlled and reproducible. The UMR 106-01 BSP cell line constitutively expresses a mature osteoblastic phenotype and is able to deposit ample amounts of apatite crystals within discrete focal sites over a 24 h incubation period after addition of an organophosphate source (19, 30) . Several findings from our laboratory support the physiological relevancy of the UMR culture model. Most notably, Wang et al. (30) have shown that the biomineralization processes in both UMR and primary osteoblast cultures are similarly regulated by parathyroid hormone treatment. Furthermore, the UMR biomineralization process is an active metabolic process requiring continuous protein synthesis and secretion (19) . Lastly, X-ray diffraction analyses demonstrate that mineral crystals formed in mineralizing UMR cultures are apatite and have a similar C-axis length as that of apatite crystals isolated from pediatric bone samples (19) . Altogether, our prior work indicates that UMR cultures deposit apatite crystals at focal sites in a physiologically relevant manner. 
Materials and methods

Antibodies
The sources of antibodies used in the study were as follows: monoclonal anti-BSP, WV1D1
(9C5) antibody was obtained from the Developmental Studies Hybridoma Bank (Univ. of Iowa, Iowa City, IA); anti-BAG-75 protein antibodies (#504) were provided by Jeff Gorski (23) .
Monospecific polyclonal antiserum raised against rat BSP (LF-87) was obtained from Larry
Fisher (NICDR, NIH) (31) . The 504 polyclonal antiserum for BAG-75 (23, 24, 26, 27) , and the WVIDI (9C5) monoclonal antibody for BSP (30) have been shown to be monospecific in light level immunolocalization, electron microscopic ultrastructural studies, and Western blot analyses.
Cell culture and treatment with β-glycerophosphate MC3T3-E1 (subclone M4) osteoblastic cells were cultured and treated with 5 mM β-glycerophosphate (β-GP) as previously described (32, 33 
Culture of fetal rat calvarial cells and treatment with β-GP
As described previously (35, 36) , calvaria were removed from 19-day fetal rats and sequentially digested with 0.2% collagenase/0.05% trypsin in HBSS 6 times for 20 minutes each. The supernatants from the first two digests were discarded and the supernatants from the remaining digests, rich in osteoblast precursor cells, were pooled for culture. Cells were plated at 2-3 x 10 8 cells per T75 flasks in α-minimal essential media supplemented with glutamine and nucleosides (Mediatech, Inc.), 10% FBS, and 0.5% penicillin/streptomycin (Pen/Strep) antibiotic. Cells were grown to confluence (3-4 days), trypsinized and then plated for experiments in chamber slides at 8000 cells /chamber. After reaching confluency, first passage cultures were re-fed every three days with medium supplemented with 5% FBS, 0.5% Pen/Strep, 100 µg/ml ascorbic acid, and with 5 mM β-GP to promote the formation and mineralization of bone mineralization foci.
Controls did not receive ßGP. At 7 and 17 days after reaching confluence, culture slides were fixed in 4% paraformaldehyde for 2.5 h at room temperature and were then stored 70% ethanol at 4°C until stained with Alizarin red S.
Visualization of apatite mineral using Alizarin red-S
After removal of medium, UMR cultures were briefly rinsed with TBS followed by fixation in ice-cold 70% ethanol for 1 h. Fixed samples were washed three times with TBS, rinsed with deionized water, and then stained for 10 min with either 40 mM or 0.4 mM Alizarin red-S dye, pH 4.2, at room temperature for brightfield (19) or epifluorescent microscopy (30), respectively.
Cultures were then rinsed five times with water followed by a 15 min wash with TBS to reduce nonspecific AR-S stain. When necessary, fixed mineralized cultures were decalcified using one 
Cell death assay
Apoptotic cells were detected in UMR cultures using a cell death detection kit (Boehringer Mannheim). Cultures were fixed in 2% paraformaldehyde in phosphate buffered saline and processed according to the manufacturer's instructions. Samples were incubated with a Terminal deoxynucleotidyl transferase dUTP Nick End Labeling (TUNEL) reaction mixture that adds fluorescein-conjugated dUTP to the free 3'-OH groups in single-and double-strained DNA fragments within apoptotic nuclei. After washing, the specimens were stained with alizarin red S (see above) and then 1 µg/ml DAPI, followed by mounting in VectaShield. All fluorochromes were detected using confocal microscopy. TUNEL specificity was determined by omitting the terminal deoxynucleotidyl transferase necessary for adding dUTP to the free 3'-OH ends of DNA strands.
Electron microscopy
For conventional electron microscopy, cultures were fixed for 24 hours with 2% glutaraldehyde in 150 mM sodium cacodylate, pH 7.2, at 4° C. Samples were post-fixed in 1% OsO 4 , dehydrated, embedded, sectioned and stained according to published protocols (19, 30) . For ultrastructural immunocytochemistry, tissue samples were fixed with 2% formaldehyde in PBS, overnight at 4° C. Samples were cryo-protected, frozen in liquid nitrogen and sectioned as described previously (37), using a method adapted from that of Tokuyasu (38) . Frozen sections 80-100 nm thick were processed for indirect immunolabeling using secondary antibodies coupled to 6 nm or 12 nm colloidal gold (Jackson Immunoresearch, West Grove, PA), under
Results
Mineralizing UMR cultures produce focal deposits of apatite that also contain BSP and alkaline phosphatase activity
When given an organophosphate stimulant like β-GP, UMR cultures deposit an apatite mineral phase by a utilization of phosphate ions released from β-GP by alkaline phosphatase (19, 30) . Figure 1A demonstrates the focal nature of the biomineralization process in UMR cultures after β-GP exposure, and also reveals the close spatial relationship between BSP and apatite deposits in this biomineralization model system. Figure 1B shows that these focal areas of apatite in UMR cultures also stain positive for alkaline phosphatase activity. BSP has been reported to accumulate quantitatively in these focal areas prior to the detection of an apatite phase, thereby meeting the necessary temporal-spatial requirements of a matrix protein involved in apatite formation (30) . However, it is not clear how BSP is targeted to these biomineralization foci (BMF) prior to mineral deposition. (Fig. 1D ). Taken together, the absence of DNA remnants, of TUNEL-positive signal, and of apoptotic bodies indicates that BMF are not apoptotic or necrotic cell debris. These results strengthen the conclusions from our previous studies (19, 30) that the biomineralization process in UMR cultures is not dystrophic.
BMF are located within the extracellular matrix between UMR cells
The 3D confocal dataset in Figure 1C shows that an average BMF is spherical in shape with typical dimensions of 10-20 µm in X-Y and 10-15 µm in the X-Z viewing planes. Notably, not all negatively charged macromolecules secreted into the extracellular space are deposited in BMF as indicated by the lack of overlap between the Alizarin red/BSP signals and hyaluronan staining (Fig. 1C) . Thus, the incorporation of BSP into BMF is unlikely to result from nonspecific electrostatic interactions. Rather, the data suggest that the strict BSP deposition in BMF is due to more specific interactions. Both sizes of BMF precursors were able to nucleate calcium phosphate crystals when UMR cultures were incubated for an additional 24 h with medium containing β-GP (i.e., 64 h to 88 h after plating). This is evident by the strong staining obtained with alizarin red-S dye binding to large (Figs. 2E, 2F , and 5E) and small BMF (Fig. 5E ). Several points can be made regarding the relative staining patterns observed when BAG-75 immunofluorescence and alizarin red-S-stained mineral crystals are imaged together. At low magnification, the stronger alizarin red-S signal displays a punctate appearance comprised of numerous 10-20 µm diameter round deposits within the interior domain of the larger BMF (Fig. 2E ). In contrast, the BAG-75
Bone Acidic Glycoprotein-75 is a biomarker for BMF precursors prior to active mineralization
immunofluorescence signal appears as a layer surrounding the alizarin red-S-stained deposits and, internally, in junctional areas separating individual alizarin red-S-stained deposits (Fig. 2F ).
In these undecalcified cultures, the regions of strongest alizarin red-S staining are seemingly devoid of apparent BAG-75 staining, while BAG-75 staining is readily visible in the outer layer surrounding the mineral deposits and within the internal areas physically separating alizarin red-S-stained round deposits. This apparent lack of BAG-75 immunogenicity deeper within these larger BMF may be due to the coverage of antigenic sites by the hydroxyapatite crystalline phase. This point is documented upon decalcification of mineralized cultures as seen in the next section.
Thus, in UMR cultures, BAG-75 is a biomarker both for BMF precursors prior to initiating mineralization, and for mature BMF containing mineral crystals regardless of size.
Within the larger BAG-75-enriched mature BMF, the apatite mineral deposits seem to be organized into small domains (10-20 µm) having sizes similar to those of the smaller BMF.
Again, this appearance suggests that the larger sized BMF precursors may represent a cluster of smaller ones.
BAG-75-enriched focal deposits represent the initial sites of mineralization in primary calvarial osteoblastic cultures
The presence of BMF in the UMR osteoblastic culture system raises the possibility that structures like these may also exist in primary osteoblastic cultures. ) that also stain positively for the presence of BAG-75 after partial decalcification using EDTA (Fig. 3J) .
Decalcification reveals that the BAG-75 content increases within BMF during active mineralization
Since the results above suggest that BAG-75 epitopes might be partially blocked by hydroxyapatite mineral deposits, it was important to show that this antigenicity could be recovered upon decalcification. To this end, replicate UMR cultures at 64 h of incubation were treated with or without β-GP supplementation for 24 h. Mineralized cultures were fixed and then decalcified using EDTA chelation (Figure 4 ) or other decalcification methods (30) . Atomic absorption measurement of elemental calcium determined that these treatments released more than 98% of the original calcium content of fully mineralized cultures (30) . In the absence of confounding mineral crystals, a large increase in BAG-75 signal is observed indicating that the BAG-75 content of BMF is substantially increased over the 24 h mineralization period (Fig. 4) .
This accumulation of BAG-75 occurs only after addition of β-GP to the UMR cultures, as control cultures not exposed to β-GP over the same time frame do not exhibit this increase in 
BSP co-localizes to large and small BMF containing BAG-75
Without β-GP, BSP is predominantly secreted into the media by UMR cells, though after β-GP is added, BSP rapidly accumulates within supramolecular complexes that subsequently mineralize (30) . We demonstrate in Figure 5 that these extracellular sites in mineralizing UMR cultures seem to be the same as BMF precursors enriched in BAG-75 and recognizable in zero-time cultures without β-GP (Figs. 2 and 4) . In fully mineralized cultures, BSP was localized within both large (Fig. 5G,H) and small (Fig. 5C,H) mature BMF, which also stained strongly for BAG-75 (Figs. 4 and 5A) . Note that the shape and boundaries of the areas of BSP staining corresponded exactly with those delimited by BAG-75 immunostaining (Fig. 5D, overlay image). The physical characteristics and BAG-75 content of the small BMF precursors seen in
Figs. 2 and 4A-D identify them as similar structures. Interestingly, although many BMF exhibited a strong immunofluorescence signal for both proteins (Fig. 5D, arrows) , some small BMF structures displayed noticeably lower levels of co-staining. These findings could be due to differences in mineral content, which may lead to blocking of antigens.
Altogether, these results demonstrate that BSP begins to accumulate in BAG-75-enriched BMF after the addition of β-GP, but prior to nucleation of hydroxyapatite crystals (30) .
Ultrastructural analysis of BMF during active mineralization of UMR cultures
The X-Z view from the confocal imaging shown in Figure 1C indicates that small BMF are roughly spherical in shape with a diameter range of 10-20 µm. The X-Z ultrastructural image of a BMF in a mineralizing UMR culture (Fig. 6A) indicates that these confocal estimates are quite accurate. The inset scanning EM image in Figure 6A also shows that the overall dimension and shape of supramolecular complexes formed by purified BAG-75 protein are similar to those of small BMF observed in mineralized UMR cultures.
BMF are filled with both thin fibrillar and granular substances (Fig. 6B ). In addition, BMF contain what appear as translucent round structures of 300-800 nm diameter, and electron opaque round structures of 50-200 nm in diameter (Figs 6, A-C). BMF did not, however, exhibit evidence of opaque, rounded structures having a classic appearance of condensed chromatin or apoptotic bodies (39, 40) . This finding is consistent with DAPI-and TUNEL-staining analyses shown in Figures 1C and 1D , respectively. A comparison of BMF during mineralization (Fig.   6C ) as compared to unmineralized controls (Fig. 6D) indicates that the only visible differences are that the former are completely filled with fibrillar, granular and vesicular structures with little void space (Fig. 6C, inset) , whereas the latter exhibit more void space and are less granular in appearance (Fig. 6D, inset) . 
Localization of BAG-75 and BSP within BMF at the ultrastructural level
Figures 2E and 2F demonstrate that the inner core of the BMF contains more apatite mineral than its outer boundaries. Within the inner core of BMF, the immunogold particles indicating the locations of BSP were generally distributed on 10-nm thin-filament fibrils (Fig. 7A, arrows) .
Towards the outer surface of BMF, BSP immunogold particles were generally associated with larger vesicles, but not the smaller ones (Figs. 7B and 7C, arrows versus arrowheads, respectively). Close inspection of the gold-particle staining pattern on these larger structures gives the impression that BSP epitopes are on the surface. This is particularly evident for the structure shown in Figure 7C (arrow) where gold particles were only observed in a location that appeared to cut tangentially across the vesicle surface. Non-immune antibody control sections typically contained a few immunogold particles, usually present in groups of one or two, but never in clusters as large as those shown here (see Figure 3C in this paper, and Figure 7E in the Gorski et al. companion paper for images of non-immune antibody staining).
Double staining for BAG-75 and BSP using different sized immunogold particle antibodies (12 nm and 6 nm, respectively) revealed that these two bone matrix proteins are colocalized in the outer boundary region of BMF ( As the earliest recognized biomarker of BMF, we hypothesize that BAG-75 serves two roles, one as a structural scaffold and the other as a source of phosphate ions for apatite nucleation. With regard to its first function, we propose that BAG-75 plays a key role in the initial assembly of the structural scaffold of BMF precursors. This is supported by evidence that purified BAG-75 protein alone is able to self-assemble into thin linear strands of up to 1 micron in length (24, 27, 41) . These BAG-75 microfibrils can coalesce to form supramolecular spherical structures of up to 10-15 microns in diameter (Fig. 5A, inset) , which have the capability to retain large quantities of phosphate ions (24) . These structures are remarkably similar in shape and dimension to the smaller BAG-75-enriched BMF identified here in UMR cultures.
We further rationalize that such a BAG-75 framework could provide key secondary Alkaline phosphatase also appears to be expressed very early during osteogenesis (44) (45) (46) , and an elevated expression of alkaline phosphatase has been used to define committed proliferating osteogenic cells (14) . As described in our BMF model of mineralization below, alkaline phosphatase is an important component of matrix vesicles (47, 48) , where it is believed to produce inorganic phosphate ions from complex phosphate sources to feed the process of crystal nucleation. Addition of alkaline phosphatase inhibitors such as levamisole blocks UMR biomineralization reactions initiated by β-GP (19) . With regard to its second functional role in UMR biomineralization, we hypothesize that the de-phosphorylation of BAG-75 protein itself could also provide a potential source of phosphate ions for apatite nucleation reactions since this protein contains an estimated 44-phosphoryl residues/mole (22) .
Debate continues regarding the underlying mechanism(s) of vertebrate biomineralization.
One view proposes that phospholipid membrane-delimited vesicles (matrix vesicles) released into the extracellular matrix by osteoblasts mediate biomineralization reactions (1, 3, 5, 8, 49) .
They are reported to exist in nearly all mineralizing tissues, but are best described in calcifying cartilage. They are small (50-200 nm diameter) vesicles containing high levels of phosphatidylserine and cardiolipin (50, 51) . They contain several enzymes including alkaline phosphatase and pyrophosphatase (52) , and have cytoskeletal (53) and matrix proteins (54) associated with their inner and outer membrane surfaces, respectively. Another biomineralization theory proposes that noncollagenous protein structures assembled within the type I collagen-rich, extracellular matrix of osteoid directly mediates the heterogeneous nucleation of apatite crystals (2, 7, 55) . Based on the presence of polyacidic domains and a capacity to nucleate hydroxyapatite in vitro, BSP has been proposed to act as such a nucleator in bone and cartilage (21) .
Yet another biomineralization theory proposes that calcified spherically shaped structures with a size range of 300-600 nm in diameter, termed crystal ghost aggregates, nucleate the initial apatite crystals within osteoid and then subsequently seed a heterogeneous nucleation reaction within the fibrillar collagen matrix (3, 4, 56, (57) (58) (59) . These mineralized structures in bone tissue stain positive with acridine orange or ruthenium red suggesting the presence of sulfate groups (4, 60) . This staining was originally interpreted as evidence for sulfated proteoglycans in these structures (61). However, it is possible that a sulfated glycoprotein could also contribute to these sulfate groups. BSP has been shown to co-localize with crystal ghost aggregates in osteoid (18) and in osteoblastic cultures (20, 30) ; it also contains several sulfate groups bound to oligosaccharides and tyrosine residues (62, 63) . Interestingly, BSP has not yet been reported to be a component of matrix vesicles (1, 47, 49, 64) . Our findings indicate that BSP is associated with a population of large vesicle-like structures, but not with the smaller matrix vesicles. In this way, BSP may define a biochemically distinct population of vesicles, which are larger than matrix vesicles. Since apatite mineral forms in association with these "bioapatite vesicles" (65),
we hypothesize that these larger vesicles may be related to, and likely an early structural stage of, the fully mineralized BSP-enriched particles referred to as crystal ghost aggregates (3, 4) .
It is suggested that the large size, amorphous character, and prior lack of an authentic biomarker for BMF precursor and mature BMF complexes may have prevented their routine detection with ultrastructural methods, which tends to emphasize discrete electron-opaque structures of uniform appearance (e.g., matrix vesicles). Despite this limitation, similar spherical, interfibrillar regions containing crystal ghost aggregates enriched in BSP and an amorphous extracellular matrix have been identified in vitro (66, 67) and in vivo (68) as sites of subsequent initial mineral nucleation. In addition, Irie et al. (67) have noted the apparent similarity between these nucleation sites in vitro and those present in membranous or primary bone. The above-mentioned studies suggest that BMF-like structures have been observed before, but seem to have been considered obscure entities lacking a clear context with respect to mineralization reactions. It is our contention that only with data such as that provided by our current study can one properly interpret the significance of these structures to the biomineralization process.
We propose a 5-step biomineralization model (Fig. 9 ) in which BMF, typically 15-25 µm in diameter, serve as a supramolecular domain that facilitates the initial sequestration of calcium and phosphate ions in an extracellular matrix environment.
Step 1 involves the determination of the boundaries, shape, and size of future mineralized matrix areas by BAG-75 expressing cells.
Step 2 involves the assembly of extracellular BMF precursor structures via BAG-75 selfassembly reactions.
Step 3 Note that calcium mineral deposits do not co-localize with either DAPI-stained or TUNELstained nuclei, and that only about 1-2% of the nuclei are TUNEL-positive in this field of view. 
